DUKSANHIMETAL Corrects Stock Option Grant: Reduced Grant Size and Increased Fair Value, Minimal Dilution Impact on Shareholders

DUKSANHIMETAL submitted a correction report on stock option grant on April 16, 2026, reflecting cancellations due to resignations from the initial filing on March 30, 2023.
The number of grantees decreased from 15 to 13, and the granted shares decreased from 79,000 to 71,000. Consequently, total outstanding options after this grant adjusted from 314,000 to 306,000 shares.
The fair value per option increased from 618.77 won to 1,661 won due to changes in valuation assumptions including higher expected volatility, lower risk-free rate, and shorter expected exercise period despite a lower underlying stock price.
The exercise price remains 6,315 won, with an exercise period from March 30, 2026 to March 29, 2028. The settlement method may be new shares, treasury shares, or cash settlement as determined by the board.
The grant represents approximately 0.16% of total outstanding shares, implying minimal dilution for existing shareholders. The stock options are intended to incentivize long-term employee retention.
[AI Summary]The company filed a minor correction reducing the scale of stock option grants to employees due to resignations, with no capital raising or governance changes. The dilution impact is negligible, thus the negative effect on share price is limited.